PDCD1 and breast carcinoma: However, due to significant limitations of these studies (e.g., Ahmed FS’s study (36), Wesolowski R’s study (37), and Loibl S’s study (38)), research into the potential significance of PD-1 and PD-L1 protein expression in breast cancer patients treated with NACT was often considered flawed or controversial.